Regenesis Biomedical

About:

Regenesis Biomedical focuses on the development of non-invasive regenerative medicine products.

Website: http://www.regenesisbio.com

Twitter/X: regenesisbio

Top Investors: Fulcrum Equity Partners, Valley Ventures, Solstice Capital, TGap Ventures, Aztec Venture Network

Description:

Regenesis Biomedical a medical technology company that focuses on developing and marketing noninvasive regenerative medicine products. The company offers Provant Therapy System, a medical device that aids in reduction of pain and swelling of skin and soft tissues following surgery. Its customers include health care facilities and providers that serve patients being treated by acute care hospitals, long-term acute care hospitals, skilled nursing facilities, rehabilitation centers, home healthcare agencies, and wound care clinics. Regenesis Biomedical was founded in 1996 and is headquartered in Scottsdale, Arizona.

Total Funding Amount:

$11.7M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Scottsdale, Arizona, United States

Founded Date:

1997-01-01

Contact Email:

info(AT)regenesisbiomedical.com

Founders:

Frank George, Mary Ritz

Number of Employees:

51-100

Last Funding Date:

2011-06-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai